NEW YORK, Sept. 5, 2019 /PRNewswire. NEWS PROVIDED BY: Muscular Dystrophy Association, Sep 05, 2019.
Critical funding provided by MDA will support studies to further understand disease mechanisms, optimize and build upon existing therapies, and advance drug target identification, especially toward gene-targeted therapies -- research that will have translational and clinical application across many neuromuscular diseases
Jordi Magrane, PhD
Weill Cornell Medical College
Research grant, $300,000
Cell and non-cell autonomous effects of frataxin deficiency in FA pathophysiology
Muscular Dystrophy Association Awards 25 Grants Totaling More Than $6.6 Million for Neuromuscular Disease Research